FORM 38.5(b)
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RECOGNISED INTERMEDIARY STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY
1. KEY INFORMATION
Name of exempt principal trader | GOLDMAN SACHS & CO. LLC |
Company dealt in | WILLIS TOWERS WATSON PLC |
Class of relevant security to which the dealings being disclosed relate (Note1) | USD 0.000304635 ordinary shares |
Date of dealing | 16 April 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 2)
| Long | Short | ||
| Number | (%) | Number | (%) |
(1) Relevant securities | 1,993,373.542 | (1.54) | 1,194,118.542 | (0.92) |
(2) Derivatives (other than options) | 648,126 | (0.50) | 2,378,896 | (1.84) |
(3) Options and agreements to purchase/sell | 0 | (0.00) | 0 | (0.00) |
Total | 2,641,499.542 | (2.04) | 3,573,014.542 | (2.77) |
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 2)
Class of relevant security: | Long | Short | ||
| Number | (%) | Number | (%) |
(1) Relevant securities |
|
|
|
|
(2) Derivatives (other than options) |
|
|
|
|
(3) Options and agreements to purchase/sell |
|
|
|
|
Total |
|
|
|
|
3. DEALINGS (Note 3)
(a) Purchases and sales
Purchase/sale | Number of relevant securities | Price per unit (Note 4) |
Purchase | 11 | 239.6900 USD |
Purchase | 89 | 240.0150 USD |
Purchase | 13 | 240.1850 USD |
Purchase | 1 | 240.4000 USD |
Purchase | 299 | 240.4000 USD |
Purchase | 7 | 240.4000 USD |
Purchase | 100 | 240.4000 USD |
Purchase | 380 | 240.4000 USD |
Purchase | 92 | 240.4000 USD |
Purchase | 2,842 | 240.4000 USD |
Purchase | 79 | 240.5000 USD |
Purchase | 100 | 240.5050 USD |
Purchase | 100 | 241.1300 USD |
Purchase | 100 | 241.2800 USD |
Purchase | 4 | 241.3550 USD |
Purchase | 2,046 | 242.2000 USD |
Sale | 15 | 239.4300 USD |
Sale | 10 | 239.5100 USD |
Sale | 6 | 239.5200 USD |
Sale | 84 | 239.5500 USD |
Sale | 80 | 239.5600 USD |
Sale | 20 | 239.5600 USD |
Sale | 84 | 239.6200 USD |
Sale | 95 | 239.6200 USD |
Sale | 95 | 239.6300 USD |
Sale | 5 | 239.6300 USD |
Sale | 1 | 239.6600 USD |
Sale | 99 | 239.6600 USD |
Sale | 5 | 239.6700 USD |
Sale | 100 | 239.6900 USD |
Sale | 100 | 239.7100 USD |
Sale | 100 | 239.7300 USD |
Sale | 40 | 239.7300 USD |
Sale | 60 | 239.7300 USD |
Sale | 100 | 239.7400 USD |
Sale | 100 | 239.7500 USD |
Sale | 11 | 239.7600 USD |
Sale | 100 | 239.7600 USD |
Sale | 15 | 239.7700 USD |
Sale | 85 | 239.7700 USD |
Sale | 5 | 239.7700 USD |
Sale | 100 | 239.7900 USD |
Sale | 3 | 239.8100 USD |
Sale | 96 | 239.8200 USD |
Sale | 1 | 239.8200 USD |
Sale | 20 | 239.8500 USD |
Sale | 20 | 239.8500 USD |
Sale | 60 | 239.8500 USD |
Sale | 7 | 239.8700 USD |
Sale | 93 | 239.8700 USD |
Sale | 28 | 239.9600 USD |
Sale | 15 | 239.9600 USD |
Sale | 28 | 239.9600 USD |
Sale | 1 | 239.9600 USD |
Sale | 8 | 239.9600 USD |
Sale | 20 | 239.9600 USD |
Sale | 100 | 239.9700 USD |
Sale | 90 | 240.0700 USD |
Sale | 10 | 240.0800 USD |
Sale | 30 | 240.1100 USD |
Sale | 86 | 240.1100 USD |
Sale | 24 | 240.1200 USD |
Sale | 26 | 240.1200 USD |
Sale | 12 | 240.1400 USD |
Sale | 50 | 240.1500 USD |
Sale | 50 | 240.1500 USD |
Sale | 12 | 240.1500 USD |
Sale | 27 | 240.1500 USD |
Sale | 22 | 240.1600 USD |
Sale | 23 | 240.1700 USD |
Sale | 100 | 240.1700 USD |
Sale | 14 | 240.1700 USD |
Sale | 100 | 240.1900 USD |
Sale | 14 | 240.2200 USD |
Sale | 14 | 240.2200 USD |
Sale | 44 | 240.2300 USD |
Sale | 24 | 240.2300 USD |
Sale | 74 | 240.2300 USD |
Sale | 24 | 240.2300 USD |
Sale | 12 | 240.2300 USD |
Sale | 32 | 240.2400 USD |
Sale | 32 | 240.2500 USD |
Sale | 1 | 240.2600 USD |
Sale | 71 | 240.2600 USD |
Sale | 4 | 240.2600 USD |
Sale | 1 | 240.2600 USD |
Sale | 44 | 240.2600 USD |
Sale | 14 | 240.2600 USD |
Sale | 100 | 240.2700 USD |
Sale | 1 | 240.2800 USD |
Sale | 10 | 240.2850 USD |
Sale | 42 | 240.2900 USD |
Sale | 100 | 240.2900 USD |
Sale | 53 | 240.3200 USD |
Sale | 4 | 240.3200 USD |
Sale | 42 | 240.3500 USD |
Sale | 100 | 240.3500 USD |
Sale | 4 | 240.3700 USD |
Sale | 54 | 240.3700 USD |
Sale | 98 | 240.3700 USD |
Sale | 100 | 240.3700 USD |
Sale | 20 | 240.3700 USD |
Sale | 2 | 240.3700 USD |
Sale | 1 | 240.3800 USD |
Sale | 21 | 240.3800 USD |
Sale | 10 | 240.3900 USD |
Sale | 1,186 | 240.4000 USD |
Sale | 791 | 240.4000 USD |
Sale | 1,821 | 240.4000 USD |
Sale | 729 | 240.4000 USD |
Sale | 42 | 240.4000 USD |
Sale | 1,145 | 240.4000 USD |
Sale | 140,000 | 240.4000 USD |
Sale | 791 | 240.4000 USD |
Sale | 325 | 240.4000 USD |
Sale | 81,000 | 240.4000 USD |
Sale | 1 | 240.4100 USD |
Sale | 95 | 240.4300 USD |
Sale | 47 | 240.4300 USD |
Sale | 5 | 240.4300 USD |
Sale | 100 | 240.4400 USD |
Sale | 46 | 240.4500 USD |
Sale | 99 | 240.4500 USD |
Sale | 100 | 240.4600 USD |
Sale | 5 | 240.4800 USD |
Sale | 94 | 240.4800 USD |
Sale | 1 | 240.5000 USD |
Sale | 100 | 240.5200 USD |
Sale | 100 | 240.5500 USD |
Sale | 20 | 240.7200 USD |
Sale | 40 | 240.7200 USD |
Sale | 20 | 240.7200 USD |
Sale | 20 | 240.7200 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 5) | Number of relevant securities (Note 6) | Price per unit (Note 4) |
CFD | Opening a long position | 4,736 | 240.0786 USD |
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name,e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 4) |
|
|
|
|
|
|
|
(ii) Exercising
Product name,e.g. call option | Number of securities | Exercise price per unit (Note 4) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 3)
Nature of transaction (Note 7) | Details | Price per unit (if applicable) (Note 4) |
|
|
|
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. |
NONE |
Is a Supplemental Form 8 attached? (Note 9) YES
Date of disclosure | 19 April 2021 |
Contact name | Paul Grainger and Kashif Rafiq |
Telephone number | +44(20) 7552 9835 / +44(20) 7051 0547 |
Name of offeree/offeror with which connected | WILLIS TOWERS WATSON PLC |
Nature of connection (Note 9) | Advisor to Offeree |
SUPPLEMENTAL FORM 38.5(b)
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
OPEN POSITIONS (Note 1)
Product name,e.g. call option | Written or purchased | Number of relevant securities to which the option or derivative relates | Exercise price (Note 2) | Type, e.g. American, European etc. | Expiry date |
Swap | Sold | 185 | 0.0000 | N/A | 23/09/2021 |
Swap | Sold | 554 | 0.0000 | N/A | 29/06/2021 |
Swap | Sold | 36,084 | 0.0000 | N/A | 16/05/2022 |
Swap | Sold | 69,482 | 0.0000 | N/A | 16/05/2022 |
Swap | Sold | 140,000 | 0.0000 | N/A | 25/03/2022 |
Swap | Sold | 140,000 | 0.0000 | N/A | 24/03/2022 |
Swap | Purchased | 597,000 | 0.0000 | N/A | 04/01/2023 |
Swap | Sold | 597,000 | 0.0000 | N/A | 04/01/2023 |
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rules 8 and 38.5 of the Rules. If in doubt, consult the Panel.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.